Search Results

7 results found for ""

  • PLGA | Nomisma Healthcare manufacturer in India, plga polymer supplier

    Quick ask Polylactic co glycolic acid #PLGA # ​ Nomisma Healthcare ​ India Poly(lactide-co-glycolide) (PLGA) is a well-established biodegradable polymer used in medical devices and drug delivery applications. The isomer of Lactic acid 01 L-Lactide D-Lactide DL-Lactide 02 Molecular Weight 03 End Group Acid- Terminired Ester- Terminated Composition of Lactide and Glycolide 04 75:25 50:50 85:15 80:20 90:10 10:90 Available varients 10kD to 120kD PLGA is used for the Control drug Delivery system in advance nano medicins. Leuprolide Depot for 1 month is one of them. Drug delivery PLGA with Vitamin C and Vitamin E Nanoparticles use in Cosmetic products. Cosmetic PLGA is used in Biodegradable orthopedic implants. A biodegradable porous orthopedic screw is one of them. Orthopedic Implants Electrospun PLGA fiber sheets incorporating fluorescent nanosensors Bio-sensor APPLICATION (Lactide: Glycolide) PLGA with different composition ratio used as APIs and Excipients in Advanced Drug Delivery formulation as Biodegradable Polymers also in Biopharmaceutical Process Development, NDDS, and Manufacturing of the Controlled Release, Excipients like Lactide, and Glycolide Polymers used in Liquid Dosage Forms, Materials Science as Poly(Lactide-co-Glycolide) (PLGA) Copolymers, Polymer Science, Products for Sustained Drug Release Injectables Poly(lactide-co-glycolide) (PLGA) ​ 50:50 DL-PLG / 50:50 Poly(DL-lactide-co-glycolide) / 0.15 - 0.25 IV /Ester ​ 50:50 DL-PLG / 50:50 Poly(DL-lactide-co-glycolide) / 0.15 - 0.25 IV /Acid ​ 50:50 DL-PLG / 50:50 Poly(DL-lactide-co-glycolide) / 0.26 - 0.54 IV /Ester ​ 50:50 DL-PLG / 50:50 Poly(DL-lactide-co-glycolide) / 0.55 - 0.75 IV /Acid ​ 50:50 DL-PLG / 50:50 Poly(DL-lactide-co-glycolide) / 0.55 - 0.75 IV /Ester ​ 50:50 DL-PLG / 50:50 Poly(DL-lactide-co-glycolide) / 0.76 - 0.94 IV /Ester ​ 50:50 DL-PLG / 50:50 Poly(DL-lactide-co-glycolide) / 0.95 - 1.20 IV /Ester ​ 65:35 DL-PLG / 65:35 Poly(DL-lactide-co-glycolide) / 0.55 - 0.75 IV /Ester ​ 65:35 DL-PLG / 65:35 Poly(DL-lactide-co-glycolide) / 0.83 - 0.93 IV /Ester ​ 75:25 DL-PLG / 75:25 Poly(DL-lactide-co-glycolide) / 0.15 - 0.25 IV /Acid ​ 75:25 DL-PLG / 75:25 Poly(DL-lactide-co-glycolide) / 0.55 - 0.75 IV /Ester ​ 75:25 DL-PLG / 75:25 Poly(DL-lactide-co-glycolide) / 0.70 - 0.90 IV /Acid ​ 75:25 DL-PLG / 75:25 Poly(DL-lactide-co-glycolide) / 0.80 - 1.20 IV /Ester ​ 85:15 DL-PLG / 85:15 Poly(DL-lactide-co-glycolide) / 0.55 - 0.75 IV /Ester ​ 85:15 DL-PLG / 85:15 Poly(DL-lactide-co-glycolide) / 0.76 - 0.85 IV /Ester ​ 55:45 DL-PLG-Glu / 55:45 Poly(DL-lactide-co-glycolide) Glucose Star Polymer / 0.40 - 0.60 IV ​ Poly lactide (PLA) ​ DL-PL / Poly(DL-lactide) / 0.26 - 0.54 IV /Ester ​ DL-PL / Poly(DL-lactide) / 0.16 - 0.25 IV / Acid ​ DL-PL / Poly(DL-lactide) / 0.55 - 0.75 IV /Ester ​ L-PL / Poly(L-lactide) / 0.15 - 0.35 IV /Ester ​ L-PL / Poly(L-lactide) / 0.90 - 1.20 IV /Ester / ACL Scrow ​ ​ ​ Polyglycolic acid (PGA) ​ ​ Polyglycolic acid for surgical suture PGA / Poly(2-hydroxyacetic acid) / 1.2 IV / Acid ​ ​ Conducting polymers ​ Polyaniline ​ At Nomisma health care, Polyaniline is a regular product in Portfolio and it is having a better quality profile against the commercially available and can be made available in small or Bulk Quantities depending upon the requirement. Lactide ​ L-Lactide CAS 4511-42-6 ​ D(+)-lactide - CAS 13076-17-0 ​ D(+)-lactide - CAS 13076-17-0 ​ DL-Lactide CAS 95-96-5 ​

  • Poly L-Lactic acid (PLLA) and Poly DL- Lactic acid (PDLLA) for biomedical device

    Cost-effective PLGA and PLA nanoparticles for Drug formulation as nanomedicine and biodegradable orthopedic implants Since its commencement, Nomisma Healthcare has acquired abilities and specialization with business backing to give its customers precise data and outstanding items as regards. With highly qualified experts, the Nomisma group has a brilliant conception of the complexities of the market and has firm associations with key collaborators to take the organization forward. At Nomisma Healthcare, PLGA i.e. Poly (lactic-co-glycolic) acid and PLA i.e. Polylactic acid Nanoparticles based polymers, are manufactured at our ISO 9001-2015 certified facility, meeting the desired quality standards for its efficient & successful use. We offer in both, the small and large scale quantities of biopolymers. We provide the best quality biodegradable polymers to become trustable global polymer suppliers, meeting the products with international pharmaceutical quality standards. Polylactic acid and Polylactic co Glycolic acids, also referred to as PLA and PLGA, are produced by ring-opening polymerization of corresponding lactide and glycolide monomers with a specific catalyst which is nontoxic. Their degradation properties and a long history of use in human products make PLGA, a desirable product for drug delivery, medical device, and combination products. The Nomisma Healthcare brand has been a reliable and proven source of these products in India and across the globe via a new technology approach at a reasonable price. At Nomisma healthcare, the range of PLGA incorporates monomer compositions of Lactic acid to glycolic acid like etc. in Poly (lactic-co-glycolic) acid. These products are offered in a range of molecular weights, as well as acid, hydroxyl and ester end groups. For different prerequisites of PLGAs, it would be ideal if you don't hesitate to contact/write to us. Also, our skilled research team can do the custom synthesis as per customer’s demands by applicable modifications in polymer synthesis. 50:50, 75:25, 85:15, 45:55, The Characterization of Polymer, to be used in complex drug formulation, is a key requirement. To fulfill this requirement considering the regulatory aspects, at Nomisma Healthcare, detailed study & analysis are done which covers the following tests. Identification by 1H-NMR. Identification by FT-IR. Inherent viscosity (IV). Monomer ratio by NMR study. End group identification by 13C NMR Block length identification by 13C NMR Water content by Karl Fischer. Glass transition temperature (Tg) by DSC. Free acid content by a titrimetric analysis. Residual monomer content by 1H-NMR Bioburden test (total aerobes, spores, and anaerobes) Our Customers Poly Lactic-Co-Glycolic Acid (PLGA) as biodegradable controlled drug delivery carrier. PLGA plays an important and Key role play when used in complex drug delivery systems and biodegradable medicinal implants. Drug loading capacity and degradation time of implant depends on • The ratio of lactide to glycolides. • End group of the polymer. • Molecular weight polymer chain. Poly L-Lactic acid (PLLA) and Poly DL- Lactic acid (PDLLA) for biomedical devices and implants Poly L-Lactic acid (PLLA) and Poly-DL-lactic acid (PDLLA) are used as bio-degradable products for films, screws, and pins. The following important parameters are considered during the manufacturing of such devices. It should be a semi-crystalline or amorphous polymer. Molecular weight about 100 kDa to 220 kDa. Melting point about 170 - 175°C Glass transition temperature (TG) about 55 - 60°C GET IN TOUCH Why Buy Our Products? NOMISMA HEALTHCARE A pioneer in the Biopolymers business in India.

  • Contact | Nomisma Healthcare

    CONTACT US J-64 BIDC-Gorwa, Behind Jyoti LTD Vadodara, Gujarat, India-390003 Submit Thanks for submitting!

  • Quality | Nomisma Healthcareplga as biodegradable controlled drug,CAS 26780-50-7,polylactic acid polyglycolic plga polymer manufacturer, plga polymer supplier

    Quality Policy Quality Objectives: Zero Defects 100% On Time Delivery 100% Customer Satisfaction Quality Policy Statement: To meet or exceed all requirements through continual improvement and striving to meet our objectives The quality is an integral part of Nomisma healthcare’s Business objectives. These objectives guide our actions to ensure all products being manufactured & distributed meet their predetermined specifications, consistently and are safe and effective for end-user. These objectives are essential for the achievement of our ambition to be recognized and trusted to offer products and services that enhance the quality of life and contribute to a healthier future. At Nomisma health care, our commitment is to never compromise on the quality, compliance, and safety of our products and services. This requires each individual’s involvement to understand their roles & responsibility and to empower each individual so as to further strengthens the organization's brand products. Our mission is to implement a robust, global quality management system so as to sustain a culture of operational excellence and quality compliance, meeting the expectations of our customers and government regulators. Continuously challenging ourselves to improve the quality management system to guarantee product safety, prevent quality incidents and eliminate defects through the review of quality objectives and results, Encouraging participation and promotion of quality responsibilities amongst all employees and third parties through standards, education, training and coaching, supervision and effective communication

  • 404 error page | Nomisma Healthcare

    We Can’t Find This Page Check the website URL and try again, or find what you need on our homepage.

  • #About Us #Nomisma Healthcare

    How We Got Here ​ “Nomisma Healthcare” is a Research & Development organization, established in the year 2018, located at BIDC, Gorwa, Vadodara in Gujarat state, India, for developing of a wide range of Biodegradable Pharmaceutical and Medical Polymers like Poly Glycolic Acid, Poly Lactic Acid, Poly Lactic Co Glycolic acid, etc. Our Objectives “Nomisma Healthcare is a micro and medium scale Research center, established with an objective of Innovative process development, process optimization and product manufacturing activity to produce and deliver various Biodegradable Pharmaceutical polymers and conducting polymers, to support the various organizations across the globe providing the cost-effective and quality products. Our Activities: Various biodegradable polymers like Poly Glycolic Acid, Poly Lactic Acid, Poly Lactic Co Glycolic acid, Poly-aniline, etc. with different molecular weights and its different composition related Products are the key areas. The developed and optimized process for Poly Glycolic Acid, Poly Lactic Acid, Poly Lactic Co Glycolic acid, etc. at Nomisma Healthcare is a greener process, which does not use any solvents, any toxic metals, are the important and remarkable futures in addition with shortened reaction time, user-friendly & environment-friendly process, giving higher quality standard product when compared with literature reported processes. ​ Our Innovative initiatives: Based on acquired knowledge by skills professionals, at Nomisma Healthcare, the processes developed are innovative i.e. free of metal alkanoates especially Tin Octanoate which is Genotoxic as per ICH guidelines and van be referred as Green chemistry process and highly useful in medicinal aspects for human beings in the devices like Biodegradable Orthopaedic implants, Advanced drug delivery system using process developed by Nomisma Health care which has approximately 60% lower cost in actual when compared with other resources of the present market. This overall makes universally beneficial to the human being across the globe.

NOMISMA HEALTHCARE

Dedicated to Life

2020 Nomisha healthcare.